ZJYL vs. SMTI, INGN, AVNS, ESTA, VERV, ATXS, CYH, CABA, KALV, and OABI
Should you be buying Jin Medical International stock or one of its competitors? The main competitors of Jin Medical International include Sanara MedTech (SMTI), Inogen (INGN), Avanos Medical (AVNS), Establishment Labs (ESTA), Verve Therapeutics (VERV), Astria Therapeutics (ATXS), Community Health Systems (CYH), Cabaletta Bio (CABA), KalVista Pharmaceuticals (KALV), and OmniAb (OABI). These companies are all part of the "medical" sector.
Sanara MedTech (NASDAQ:SMTI) and Jin Medical International (NASDAQ:ZJYL) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, dividends, community ranking, earnings, risk and media sentiment.
Sanara MedTech currently has a consensus target price of $44.00, suggesting a potential upside of 44.22%. Given Jin Medical International's higher probable upside, analysts clearly believe Sanara MedTech is more favorable than Jin Medical International.
Sanara MedTech has a beta of 1.67, suggesting that its stock price is 67% more volatile than the S&P 500. Comparatively, Jin Medical International has a beta of 18.8, suggesting that its stock price is 1,780% more volatile than the S&P 500.
Jin Medical International has a net margin of 0.00% compared to Jin Medical International's net margin of -7.19%. Sanara MedTech's return on equity of 0.00% beat Jin Medical International's return on equity.
Sanara MedTech received 18 more outperform votes than Jin Medical International when rated by MarketBeat users.
Jin Medical International has lower revenue, but higher earnings than Sanara MedTech.
8.1% of Sanara MedTech shares are owned by institutional investors. 54.1% of Sanara MedTech shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
In the previous week, Sanara MedTech had 14 more articles in the media than Jin Medical International. MarketBeat recorded 14 mentions for Sanara MedTech and 0 mentions for Jin Medical International. Sanara MedTech's average media sentiment score of 0.00 beat Jin Medical International's score of -0.17 indicating that Jin Medical International is being referred to more favorably in the news media.
Summary
Sanara MedTech beats Jin Medical International on 7 of the 12 factors compared between the two stocks.
Get Jin Medical International News Delivered to You Automatically
Sign up to receive the latest news and ratings for ZJYL and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ZJYL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Jin Medical International Competitors List
Related Companies and Tools
